Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
Despite recent advances in the treatment of multiple myeloma (MM), it remains an incurable disease potentially due to the presence of resistant myeloma cancer stem cells (MM-CSC). Although the presence of clonogenic cells in MM was described three decades ago, the phenotype of MM-CSC is still contro...
Enregistré dans:
Auteurs principaux: | Teresa Paíno, María E Sarasquete, Bruno Paiva, Patryk Krzeminski, Laura San-Segundo, Luis A Corchete, Alba Redondo, Mercedes Garayoa, Ramón García-Sanz, Norma C Gutiérrez, Enrique M Ocio, Jesús F San-Miguel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3ed73b7d077a49e0b8fcf3a00b27cc9c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study
par: Mousa A Al-Abbadi, et autres
Publié: (2016) -
Acta No. 138
par: Banco Central de Chile
Publié: (2019) -
MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
par: Margaret Yeh, et autres
Publié: (2021) -
Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138– CD34– tumor stem-like cells in multiple myeloma-bearing mice
par: Yang C, et autres
Publié: (2013) -
EVALUATION OF ENDOMETRIAL BIOPSIES FOR CHRONIC ENDOMETRITIS BY USING SYNDECAN-1 (CD138) IN ABNORMAL UTERINE BLEEDING
par: Aaminah Hanif, et autres
Publié: (2019)